Related references
Note: Only part of the references are listed.Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease - A meta-analysis
Elias Zintzaras et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches
Elias Zintzaras et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes:: a Go-DARTS study
Louise A. Donnelly et al.
PHARMACOGENETICS AND GENOMICS (2008)
Tolerability of statins is not linked to CYP450 polymorphisms, but reduced CYP2D6 metabolism improves cholesteraemic response to simvastatin and fluvastatin
Piergiorgio Zuccaro et al.
PHARMACOLOGICAL RESEARCH (2007)
Apolipoprotein E genotype affects the response to lipid-lowering therapy in Chinese patients with type 2 diabetes mellitus
S. Tavintharan et al.
DIABETES OBESITY & METABOLISM (2007)
Clinical implications of pharmacogenomics of statin treatment
L. M. Mangravite et al.
PHARMACOGENOMICS JOURNAL (2006)
The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate
Dimitrios S. Christidis et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS)
AH Maitland-van der Zee et al.
ACTA CARDIOLOGICA (2006)
C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies
Elias Zintzaras
PSYCHIATRIC GENETICS (2006)
Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis
Elias Zintzaras
JOURNAL OF HUMAN GENETICS (2006)
Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects
M Fiegenbaum et al.
CLINICA CHIMICA ACTA (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
An association study of 43 SNPs in 16 candidate genes with atorvastatin response
JF Thompson et al.
PHARMACOGENOMICS JOURNAL (2005)
Meta-analysis: Apolipoprotein E genotypes and risk for coronary heart disease
YQ Song et al.
ANNALS OF INTERNAL MEDICINE (2004)
Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management
K Kajinami et al.
ATHEROSCLEROSIS (2004)
Pharmacogenetic study of statin therapy and cholesterol reduction
DI Chasman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
The effectiveness of hydroxy-methylglutaryl coenzyme A reductase inhibitors (statins) in the elderly is not influenced by apolipoprotein E genotype
AH Maitland-van der Zee et al.
PHARMACOGENETICS (2002)
Genetic polymorphisms: importance for response to HMG-CoA reductase inhibitors
AH Maitland-van der Zee et al.
ATHEROSCLEROSIS (2002)
Effect of apoE genotype on the hypolipidaemic response to pravastatin in an outpatient setting
R Peña et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Apolipoprotein E polymorphism and cardiovascular disease: A HuGE review
JE Eichner et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Replication validity of genetic association studies
JPA Ioannidis et al.
NATURE GENETICS (2001)
Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis
JAC Sterne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3
T Kobayashi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner
J Pedro-Botet et al.
ATHEROSCLEROSIS (2001)
Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy
CM Ballantyne et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
The apolipoprotein ε4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction -: A substudy of the Scandinavian Simvastatin Survival Study
LU Gerdes et al.
CIRCULATION (2000)
Share Paper
